Maximizing use of available population-based data on cardiometabolic diseases

Global Health & Population Project on Access to Care for Cardiometabolic Diseases (HPACC)

doi:10.1016/S2213-8587(21)00328-4

Maximizing use of available population-based data on cardiometabolic diseases

Global Health & Population Project on Access to Care for Cardiometabolic Diseases (HPACC)

Applied Health Sciences

Research output: Contribution to journal › Article › peer-review

39 Downloads (Pure)

Abstract

The worldwide burden of adult cardiometabolic diseases such as hypertension, diabetes, obesity, and dyslipidaemia continues its relentless increase. Scaling up the prevention, management, and control of cardiometabolic diseases is cost-effective but requires strong health systems. 1 As we have previously argued in this journal, 2 building these health systems requires data that is accurate, timely, and transparent. Data from high-quality population-based surveys are particularly essential, as they reflect the spectrum of adults living in communities, including those who are not reached by their health system.
To read this article in full you will need to m

Original language	English
Journal	The Lancet Diabetes and Endocrinology
Early online date	8 Jan 2022
DOIs	https://doi.org/10.1016/S2213-8587(21)00328-4
Publication status	E-pub ahead of print - 8 Jan 2022

Bibliographical note

Not yet published in issue as of 11/01/2022

Access to Document

10.1016/S2213-8587(21)00328-4Licence: None: All rights reserved

FloodD2021MaximizingAccepted author manuscript, 296 KBLicence: Creative Commons: Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)

Cite this

@article{200d181ebda446079b672b40df398b9b,

title = "Maximizing use of available population-based data on cardiometabolic diseases",

abstract = "The worldwide burden of adult cardiometabolic diseases such as hypertension, diabetes, obesity, and dyslipidaemia continues its relentless increase. Scaling up the prevention, management, and control of cardiometabolic diseases is cost-effective but requires strong health systems. 1 As we have previously argued in this journal, 2 building these health systems requires data that is accurate, timely, and transparent. Data from high-quality population-based surveys are particularly essential, as they reflect the spectrum of adults living in communities, including those who are not reached by their health system. To read this article in full you will need to m",

author = "\{Global Health \& Population Project on Access to Care for Cardiometabolic Diseases (HPACC)\} and David Flood and David Guwatudde and Albertino Damasceno and Jennifer Manne-Goehler and Justine Davies",

note = "Not yet published in issue as of 11/01/2022",

year = "2022",

month = jan,

day = "8",

doi = "10.1016/S2213-8587(21)00328-4",

language = "English",

journal = "The Lancet Diabetes and Endocrinology",

issn = "2213-8587",

publisher = "Elsevier",

}

TY - JOUR

T1 - Maximizing use of available population-based data on cardiometabolic diseases

AU - Global Health & Population Project on Access to Care for Cardiometabolic Diseases (HPACC)

AU - Flood, David

AU - Guwatudde, David

AU - Damasceno , Albertino

AU - Manne-Goehler, Jennifer

AU - Davies, Justine

N1 - Not yet published in issue as of 11/01/2022

PY - 2022/1/8

Y1 - 2022/1/8

N2 - The worldwide burden of adult cardiometabolic diseases such as hypertension, diabetes, obesity, and dyslipidaemia continues its relentless increase. Scaling up the prevention, management, and control of cardiometabolic diseases is cost-effective but requires strong health systems. 1 As we have previously argued in this journal, 2 building these health systems requires data that is accurate, timely, and transparent. Data from high-quality population-based surveys are particularly essential, as they reflect the spectrum of adults living in communities, including those who are not reached by their health system. To read this article in full you will need to m

AB - The worldwide burden of adult cardiometabolic diseases such as hypertension, diabetes, obesity, and dyslipidaemia continues its relentless increase. Scaling up the prevention, management, and control of cardiometabolic diseases is cost-effective but requires strong health systems. 1 As we have previously argued in this journal, 2 building these health systems requires data that is accurate, timely, and transparent. Data from high-quality population-based surveys are particularly essential, as they reflect the spectrum of adults living in communities, including those who are not reached by their health system. To read this article in full you will need to m

UR - http://www.thelancet.com/journals/landia/issue/current

U2 - 10.1016/S2213-8587(21)00328-4

DO - 10.1016/S2213-8587(21)00328-4

M3 - Article

SN - 2213-8587

JO - The Lancet Diabetes and Endocrinology

JF - The Lancet Diabetes and Endocrinology

ER -

Maximizing use of available population-based data on cardiometabolic diseases

Abstract

Bibliographical note

Access to Document

Fingerprint

Cite this